Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial - Wiseman, GA; Gordon, LI; Multani, PS (Blood, 2002)